0000899243-20-005308.txt : 20200220 0000899243-20-005308.hdr.sgml : 20200220 20200220164955 ACCESSION NUMBER: 0000899243-20-005308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200218 FILED AS OF DATE: 20200220 DATE AS OF CHANGE: 20200220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linetsky David CENTRAL INDEX KEY: 0001776729 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 20635929 MAIL ADDRESS: STREET 1: C/O PHREESIA, INC. STREET 2: 432 PARK AVENUE S., 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: NY ZIP: 10016 BUSINESS PHONE: 646-747-9959 MAIL ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-18 0 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 432 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 0 1 0 0 SVP, Life Sciences Common Stock 2020-02-18 4 S 0 2844 32.8374 D 86639 D Common Stock 2020-02-18 4 S 0 344 32.9308 D 86295 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. /s/ Charles Kallenbach by Power of Attorney for David Linetsky 2020-02-19